Insiders · PAHC

Jonathan Bendheim

Director at Phibro Animal Health Corp (PAHC)

Jonathan Bendheim has filed 2 insider reports with the SEC since August 2025, as director at Phibro Animal Health Corp (PAHC). The latest filing, on August 10, 2026, reports grant or award at Phibro Animal Health Corp (PAHC).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Jonathan Bendheim is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Phibro Animal Health Corp logo
PAHC
Phibro Animal Health Corp
Director5,984$33.29Aug 10, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Jonathan Bendheim with

Other insiders at the same companies

Questions about Jonathan Bendheim

What is Jonathan Bendheim's role at Phibro Animal Health Corp?
Jonathan Bendheim reports to the SEC as director at Phibro Animal Health Corp (PAHC), according to the latest filing on August 10, 2026.
How many shares does Jonathan Bendheim own?
After the latest filing that states it, Jonathan Bendheim directly owned 5,984 shares of Phibro Animal Health Corp (PAHC). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Jonathan Bendheim bought or sold stock recently?
No open-market purchases or sales by Jonathan Bendheim are on file. The filings report grant or award.
How do I get alerts when Jonathan Bendheim files?
Follow Jonathan Bendheim on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Jonathan Bendheim (SEC CIK 0001751891). Totals count each trade once, skipping amendments whose original is on file, from Aug 19, 2025 on. View on SEC EDGAR · Get this as JSON